In summary, NFIL3 protein is elevated in TNBCs compared with both normal breast tissues and other subtypes of breast cancer, and promotes the progression of TNBC cells by activating the NF-κB signaling pathway through suppressing the expression of NFKBIA. This evidence concerns the gene NFIL3 and breast cancer.